{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T20:02:10Z","timestamp":1790193730119,"version":"4.1.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2013,5,18]],"date-time":"2013-05-18T00:00:00Z","timestamp":1368835200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diabetologia"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1007\/s00125-013-2920-2","type":"journal-article","created":{"date-parts":[[2013,5,16]],"date-time":"2013-05-16T23:28:27Z","timestamp":1368746907000},"page":"1802-1812","source":"Crossref","is-referenced-by-count":66,"title":["Amorfrutin B is an efficient natural peroxisome proliferator-activated receptor gamma (PPAR\u03b3) agonist with potent glucose-lowering properties"],"prefix":"10.1007","volume":"56","author":[{"given":"C.","family":"Weidner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. J.","family":"Wowro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Freiwald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Kawamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Witzke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Kliem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Siems","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"M\u00fcller-Kuhrt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F. C.","family":"Schroeder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Sauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,5,18]]},"reference":[{"key":"2920_CR1","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/nm0106-75","volume":"12","author":"S Smyth","year":"2006","unstructured":"Smyth S, Heron A (2006) Diabetes and obesity: the twin epidemics. Nat Med 12:75\u201380","journal-title":"Nat Med"},{"key":"2920_CR2","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1038\/nature05482","volume":"444","author":"SE Kahn","year":"2006","unstructured":"Kahn SE, Hull RL, Utzschneider KM (2006) Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 444:840\u2013846","journal-title":"Nature"},{"key":"2920_CR3","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1146\/annurev.med.53.082901.104018","volume":"53","author":"J Berger","year":"2002","unstructured":"Berger J, Moller DE (2002) The mechanisms of action of PPARs. Ann Rev Med 53:409\u2013435","journal-title":"Ann Rev Med"},{"key":"2920_CR4","doi-asserted-by":"crossref","unstructured":"(2010) Regulators restrict Avandia in the US and suspend it in the EU. Nat Rev Drug Discov 9:828\u2013829","DOI":"10.1038\/nrd3317"},{"key":"2920_CR5","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1056\/NEJMp1008233","volume":"363","author":"CJ Rosen","year":"2010","unstructured":"Rosen CJ (2010) Revisiting the rosiglitazone story\u2014lessons learned. N Engl J Med 363:803\u2013806","journal-title":"N Engl J Med"},{"key":"2920_CR6","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/j.1365-2362.2005.01456.x","volume":"35","author":"CA Argmann","year":"2005","unstructured":"Argmann CA, Cock TA, Auwerx J (2005) Peroxisome proliferator-activated receptor gamma: the more the merrier? Eur J Clin Investig 35:82\u201392, discussion 80","journal-title":"Eur J Clin Investig"},{"key":"2920_CR7","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1038\/sj.embor.7400082","volume":"5","author":"TA Cock","year":"2004","unstructured":"Cock TA, Houten SM, Auwerx J (2004) Peroxisome proliferator-activated receptor-gamma: too much of a good thing causes harm. EMBO Rep 5:142\u2013147","journal-title":"EMBO Rep"},{"key":"2920_CR8","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1038\/nrd1551","volume":"3","author":"H Gronemeyer","year":"2004","unstructured":"Gronemeyer H, Gustafsson JA, Laudet V (2004) Principles for modulation of the nuclear receptor superfamily. Nat Rev Drug Discov 3:950\u2013964","journal-title":"Nat Rev Drug Discov"},{"key":"2920_CR9","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1517\/14728214.11.3.379","volume":"11","author":"B Pourcet","year":"2006","unstructured":"Pourcet B, Fruchart JC, Staels B, Glineur C (2006) Selective PPAR modulators, dual and pan PPAR agonists: multimodal drugs for the treatment of type 2 diabetes and atherosclerosis. Expert Opin Emerg Drugs 11:379\u2013401","journal-title":"Expert Opin Emerg Drugs"},{"key":"2920_CR10","doi-asserted-by":"crossref","first-page":"7257","DOI":"10.1073\/pnas.1116971109","volume":"109","author":"C Weidner","year":"2012","unstructured":"Weidner C, de Groot JC, Prasad A et al (2012) Amorfrutins are potent antidiabetic dietary natural products. Proc Natl Acad Sci USA 109:7257\u20137262","journal-title":"Proc Natl Acad Sci USA"},{"key":"2920_CR11","doi-asserted-by":"crossref","unstructured":"de Groot JC, Weidner C, Krausze J, et al. (2013) Structural characterization of amorfrutins bound to the peroxisome proliferator-activated receptor gamma. J Med Chem. 56:1535\u20131543","DOI":"10.1021\/jm3013272"},{"key":"2920_CR12","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1126\/science.1066285","volume":"294","author":"H Masuzaki","year":"2001","unstructured":"Masuzaki H, Paterson J, Shinyama H et al (2001) A transgenic model of visceral obesity and the metabolic syndrome. Science 294:2166\u20132170","journal-title":"Science"},{"key":"2920_CR13","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.2337\/db08-0477","volume":"57","author":"T Cadoudal","year":"2008","unstructured":"Cadoudal T, Distel E, Durant S et al (2008) Pyruvate dehydrogenase kinase 4: regulation by thiazolidinediones and implication in glyceroneogenesis in adipose tissue. Diabetes 57:2272\u20132279","journal-title":"Diabetes"},{"key":"2920_CR14","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.2337\/diabetes.48.9.1830","volume":"48","author":"Y Tang","year":"1999","unstructured":"Tang Y, Osawa H, Onuma H, Nishimiya T, Ochi M, Makino H (1999) Improvement in insulin resistance and the restoration of reduced phosphodiesterase 3B gene expression by pioglitazone in adipose tissue of obese diabetic KKAy mice. Diabetes 48:1830\u20131835","journal-title":"Diabetes"},{"key":"2920_CR15","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1124\/mol.108.044826","volume":"74","author":"ES Muise","year":"2008","unstructured":"Muise ES, Azzolina B, Kuo DW et al (2008) Adipose fibroblast growth factor 21 is up-regulated by peroxisome proliferator-activated receptor gamma and altered metabolic states. Mol Pharmacol 74:403\u2013412","journal-title":"Mol Pharmacol"},{"key":"2920_CR16","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/nature09291","volume":"466","author":"JH Choi","year":"2010","unstructured":"Choi JH, Banks AS, Estall JL et al (2010) Anti-diabetic drugs inhibit obesity-linked phosphorylation of PPARgamma by Cdk5. Nature 466:451\u2013456","journal-title":"Nature"},{"key":"2920_CR17","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/j.1464-5491.2007.02029.x","volume":"24","author":"C Shetty","year":"2007","unstructured":"Shetty C, Balasubramani M, Capps N, Milles J, Ramachandran S (2007) Paradoxical HDL-C reduction during rosiglitazone and fibrate treatment. Diabet Med 24:94\u201397","journal-title":"Diabet Med"},{"key":"2920_CR18","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1146\/annurev-immunol-031210-101322","volume":"29","author":"MF Gregor","year":"2011","unstructured":"Gregor MF, Hotamisligil GS (2011) Inflammatory mechanisms in obesity. Annu Rev Immunol 29:415\u2013445","journal-title":"Annu Rev Immunol"},{"key":"2920_CR19","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nmeth.1806","volume":"9","author":"MH Tschop","year":"2012","unstructured":"Tschop MH, Speakman JR, Arch JR et al (2012) A guide to analysis of mouse energy metabolism. Nat Methods 9:57\u201363","journal-title":"Nat Methods"},{"key":"2920_CR20","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.cell.2012.01.020","volume":"148","author":"L Qiang","year":"2012","unstructured":"Qiang L, Accili D (2012) FGF21 and the second coming of PPARgamma. Cell 148:397\u2013398","journal-title":"Cell"},{"key":"2920_CR21","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.cell.2011.11.062","volume":"148","author":"PA Dutchak","year":"2012","unstructured":"Dutchak PA, Katafuchi T, Bookout AL et al (2012) Fibroblast growth factor-21 regulates PPARgamma activity and the antidiabetic actions of thiazolidinediones. Cell 148:556\u2013567","journal-title":"Cell"}],"container-title":["Diabetologia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-013-2920-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00125-013-2920-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-013-2920-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T07:49:48Z","timestamp":1558597788000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00125-013-2920-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5,18]]},"references-count":21,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["2920"],"URL":"https:\/\/doi.org\/10.1007\/s00125-013-2920-2","relation":{},"ISSN":["0012-186X","1432-0428"],"issn-type":[{"value":"0012-186X","type":"print"},{"value":"1432-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,5,18]]}}}